@article{article, title  = {{The cost-effectiveness of sequences of biological disease-modifying antirheumatic drug treatment in England for patients with rheumatoid arthritis who can tolerate methotrexate.}},

 publisher = {{Journal of Rheumatology}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/108569 https://doi.org/10.3899/jrheum.160941 }},

 year = {{2017}},

 month = {{7}},

 author = {{Stevenson MD and Wailoo AJ and Tosh JC and Hernandez-Alava M and Gibson L and Stevens JW and Archer R and Simpson EL and Hock ES and Young A and Scott DL}},

 doi = {{10.3899/jrheum.160941}},

 volume = {{44}},

 journal = {{Journal of Rheumatology}},

 issue = {{7}},

 pages = {{973-980}},

 note = {{Accessed on 2025/10/31}}}